|Page (1) of 1 - 09/05/17||email article||print page|
(September 05, 2017)
Dublin, Sept. 05, 2017 (GLOBE NEWSWIRE) -- The "PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)" report has been added to Research and Markets' offering.
The report contains profiles of companies in the market, reflecting the wide range NAAT products and applications in both the life science PCR market and the clinical PCR market. A wide range of industry players is examined, including companies marketing NAAT instruments and/or consumables to the life science research market, companies developing or marketing in vitro diagnostic (IVD) NAAT platforms and tests to clinical laboratories, diagnostic companies offering NAAT tests as a service via their own CLIA-certified laboratory, companies developing or marketing NAAT platforms and tests for rapid point-of-care or near-patient testing, companies developing or marketing PCR-based sample/library preparation products or test panels for DNA sequencing, companies developing or marketing mass spectrometry platforms that include PCR amplification before analysis by mass spectrometry, and companies developing or marketing other technology platforms that include PCR amplification as an initial or early step.
Beyond these market size and regional estimates and forecasts for both the life science (research) and diagnostic uses of PCR, the report provides an overview of PCR and other NAAT technologies, in addition to discussion of applications of NAAT in life science and clinical diagnostics.
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter